(c) 2022 PillSync.com

eszopiclone tablet film coated

1 INDICATIONS AND USAGE Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). Eszopiclone tablets are indicated for the treatment of insomnia. Eszopiclone tablets have been shown to decrease sleep latency and improve sleep maintenance ( 1 ).

glenmark pharmaceuticals inc. usa


2 years ago ROUND WHITE G 383 eszopiclone tablet film coated

ROUND WHITE G 383

16 HOW SUPPLIED/STORAGE AND HANDLING

ESZOPICLONE Tablets, USP, 3 mg are round, dark blue, film-coated, and identified with debossed markings of ‘384’ on one side, and ‘G’ on the other side and are supplied as: NDC 68462-384-30 bottle of 30 tablets NDC 68462-384-01 bottle of 100 tablets NDC 68462-384-10 bottle of 1000 tablets

ESZOPICLONE Tablets, USP, 2 mg are round, white to off-white, film-coated, and identified with debossed markings of ‘383’ on one side, and ‘G’ on the other side and are supplied as: NDC 68462-383-01 bottle of 100 tablets NDC 68462-383-10 bottle of 1000 tablets

ESZOPICLONE Tablets, USP, 1 mg are round, light blue, film-coated, and identified with debossed markings of ‘382’ on one side, and ‘G’ on the other side and are supplied as: NDC 68462-382-30 bottle of 30 tablets NDC 68462-382-01 bottle of 100 tablets NDC 68462-382-10 bottle of 1000 tablets Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°F to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

More pills like ROUND G 383

Related Pills

eszopiclone tablet film coated

glenmark pharmaceuticals inc. usa

eszopiclone tablet film coated

glenmark pharmaceuticals inc. usa












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site